Last reviewed · How we verify
NCT04666233
Personal Protective Equipment for the Prevention of SARS-Cov-2 During Neonatal Resuscitation
NA trial testing Neonatal resuscitation with PPE for the prevention of SARS-Cov-2 infection in Neonates Needing Resuscitation at Birth in 48 participants. Completed in 23 March 2021.
23 March 2021
Quick facts
| Lead sponsor | University Hospital Padova |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 48 |
| Start date | 16 March 2021 |
| Primary completion | 23 March 2021 |
| Estimated completion | 23 March 2021 |
| Sites | 2 locations across Italy |
Drugs / interventions tested
- Neonatal resuscitation with PPE for the prevention of SARS-Cov-2 infection
- Neonatal resuscitation without PPE for the prevention of SARS-Cov-2 infection
Conditions studied
- Neonates Needing Resuscitation at Birth — all drugs for Neonates Needing Resuscitation at Birth →
Sponsor
University Hospital Padova
Who can join
Eligibility, any sex, with Neonates Needing Resuscitation at Birth. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There has been an increasing number of SARS-CoV-2 infections in pregnant women and neonates. Interventions including open airway suctioning, positive pressure ventilation, non-invasive respiratory support, tracheal intubation, and endotracheal drug administration are aerosol-generating medical procedures and may create a risk to the unprotected healthcare providers. The impact of using personal protective equipment during neonatal resuscitation maneuvers is unknown. The objective of this study will be to compare the beginning of PPV and the duration of intubation between performing resuscitation with PPE for the prevention of SARS-Cov-2 infection and resuscitation without PPE for the prevention of SARS-Cov-2 infection.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of personal protective equipment on neonatal resuscitation procedures: a randomised, cross-over, simulation study.
Cavallin F, Lupi F, Bua B, Bellutti M, et al · · 2022 · cited 6× · PMID 34489350 · DOI 10.1136/archdischild-2021-322216
Verify or expand the search:
- PubMed search for NCT04666233
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital Padova trials
Trials by the same sponsor.
- NCT07161752 — Applied Forces During Neonatal Ventilation With Different Face Masks · NA · completed
- NCT06420115 — Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects · NA · recruiting
- NCT06276413 — REgistRy BRAnch goRE EndopRosthEsis · not yet recruiting
- NCT06254651 — Resuscitation Table Height for Face-mask Ventilation in Infants · NA · completed
- NCT06161389 — Applied Forces During Neonatal Face Mask Ventilation With Different Face-mask Air Cushion Volumes · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04666233 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Padova
- Last refreshed: 1 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04666233.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing